SCHEMBL22889111

SCHEMBL22889111

c1ccc(-c2cccc(-c3nc(-c4ccccc4-c4ccccc4)nc(-c4cccc5c4oc4ccccc45)n3)c2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.47
GGPS1 O95749 1/20 0.40
MAPT P10636 5/20 0.40
ALDH1A1 P00352 2/20 0.39
KDM4E B2RXH2 2/20 0.39
POLB P06746 1/20 0.39
PLA2G2A P14555 2/20 0.39
PLA2G4A P47712 2/20 0.39
PRKDC P78527 3/20 0.39
PIK3CD O00329 1/20 0.39
PIK3CB P42338 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
PTGES2 Q9H7Z7 1/20 0.38
TSHR P16473 2/20 0.37
HPGD P15428 1/20 0.37
MEN1 O00255 1/20 0.37
CSF1R P07333 1/20 0.37
PDGFRB P09619 1/20 0.37
KIT P10721 1/20 0.37
FLT3 P36888 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23027681 0.97 ALOX5 (0.51) ALOX5GGPS1MAPTALDH1A1KDM4E
SCHEMBL23027645 0.97 ALOX5 (0.51) ALOX5GGPS1MAPTALDH1A1KDM4E
SCHEMBL22544857 0.97 ALOX5 (0.49) ALOX5GGPS1MAPTALDH1A1KDM4E
SCHEMBL22889418 0.97 ALOX5 (0.49) ALOX5GGPS1MAPTALDH1A1KDM4E
SCHEMBL22888939 0.97 ALOX5 (0.49) ALOX5GGPS1MAPTALDH1A1KDM4E
SCHEMBL23027678 0.96 ALOX5 (0.50) ALOX5GGPS1MAPTALDH1A1KDM4E
SCHEMBL23027640 0.96 ALOX5 (0.50) ALOX5GGPS1MAPTALDH1A1KDM4E
SCHEMBL23027679 0.96 ALOX5 (0.53) ALOX5GGPS1MAPTALDH1A1KDM4E
SCHEMBL23027649 0.96 ALOX5 (0.50) ALOX5GGPS1MAPTALDH1A1KDM4E
SCHEMBL23027647 0.96 ALOX5 (0.50) ALOX5GGPS1MAPTALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11765972-B2 Compound and organic electroluminescence device using the same IDEMITSU KOSAN CO., LTD. (JP) 2023-09-19 US disclosed
US-11765972-B2 Compound and organic electroluminescence device using the same IDEMITSU KOSAN CO., LTD. (JP) 2023-09-19 US disclosed
US-20210009527-A1 COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME IDEMITSU KOSAN CO.,LTD. (JP) 2021-01-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210009527-A1 COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME OR10J3, RPS4Y1, AR ALOX5 3163/4885GGPS1 3177/4885MAPT 2178/4885
US-11765972-B2 Compound and organic electroluminescence device using the same AR, OR10J3, RPS4Y1 ALOX5 3071/4885GGPS1 3231/4885MAPT 2233/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.